country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-155580

Copy Link Print Information

MAO A/HSP90-IN-2

MAO A/HSP90-IN-2 (compound 4-C) is a dual inhibitor of HSP90and MAO A with the IC₅₀ values of 0.016 and 4.58 μM, respectively. MAO A/HSP90-IN-2 increases HSP70 expression and reduces HER2 and phospho-Akt expression, and decreases IFN-γ induced PD-L1 expression in GL26 cells. MAO A/HSP90-IN-2 inhibits the growth of Temozolomide (HY-17364) -sensitive and -resistant GBM cells, colon cancer, leukemia, non-small cell lung and other cancers, and has potential to inhibit tumor immune escape^[1].

For research use only. We do not sell to patients.

CAS No.: 2927489-99-2
Formula: C₂₅H₃₁ClN₂O₄
Molecular Weight:458.98

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (270 KB)

MAO A/HSP90-IN-2 Chemical Structure

CAS No.: 2927489-99-2

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target

MAO-A

4.58 μM (IC₅₀)

HSP90

0.016 μM (IC₅₀)

All Monoamine Oxidase Isoforms :

MAO-A
MAO-B

All HSP Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
A 172	IC₅₀	0.89 μM Compound: 4-c	Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method	[PMID: 37172473]
A549	GI₅₀	0.14 μM Compound: 4-c	Growth inhibition of human A549 cells incubated for 48 hrs by SRB assay Growth inhibition of human A549 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
HCT-116	GI₅₀	0.08 μM Compound: 4-c	Growth inhibition of human HCT-116 cells incubated for 48 hrs by SRB assay Growth inhibition of human HCT-116 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
HL-60	GI₅₀	0.06 μM Compound: 4-c	Growth inhibition of human HL-60 cells incubated for 48 hrs by SRB assay Growth inhibition of human HL-60 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
K562	GI₅₀	0.07 μM Compound: 4-c	Growth inhibition of human K562 cells incubated for 48 hrs by SRB assay Growth inhibition of human K562 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
KM12	GI₅₀	0.06 μM Compound: 4-c	Growth inhibition of human KM12 cells incubated for 48 hrs by SRB assay Growth inhibition of human KM12 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
LN-229	IC₅₀	0.31 μM Compound: 4-c	Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method	[PMID: 37172473]
NCI-H460	GI₅₀	0.05 μM Compound: 4-c	Growth inhibition of human NCI-H460 cells incubated for 48 hrs by SRB assay Growth inhibition of human NCI-H460 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
NCI-H522	GI₅₀	0.07 μM Compound: 4-c	Growth inhibition of human NCI-H522 cells incubated for 48 hrs by SRB assay Growth inhibition of human NCI-H522 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
RPMI-8226	GI₅₀	0.33 μM Compound: 4-c	Growth inhibition of human RPMI-8226 cells incubated for 48 hrs by SRB assay Growth inhibition of human RPMI-8226 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
SF-268	GI₅₀	1.43 μM Compound: 4-c	Growth inhibition of human SF-268 cells incubated for 48 hrs by SRB assay Growth inhibition of human SF-268 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
SF-295	GI₅₀	0.32 μM Compound: 4-c	Growth inhibition of human SF-295 cells incubated for 48 hrs by SRB assay Growth inhibition of human SF-295 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
SF-539	GI₅₀	0.31 μM Compound: 4-c	Growth inhibition of human SF-539 cells incubated for 48 hrs by SRB assay Growth inhibition of human SF-539 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
SNB-19	GI₅₀	0.44 μM Compound: 4-c	Growth inhibition of human SNB-19 cells incubated for 48 hrs by SRB assay Growth inhibition of human SNB-19 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
SNB-75	GI₅₀	0.86 μM Compound: 4-c	Growth inhibition of human SNB-75 cells incubated for 48 hrs by SRB assay Growth inhibition of human SNB-75 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
SW-620	GI₅₀	0.24 μM Compound: 4-c	Growth inhibition of human SW-620 cells incubated for 48 hrs by SRB assay Growth inhibition of human SW-620 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
T98G	IC₅₀	0.46 μM Compound: 4-c	Antiproliferative activity against human T98G cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method Antiproliferative activity against human T98G cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method	[PMID: 37172473]
U-251	GI₅₀	0.37 μM Compound: 4-c	Growth inhibition of human U-251 cells incubated for 48 hrs by SRB assay Growth inhibition of human U-251 cells incubated for 48 hrs by SRB assay	[PMID: 37172473]
U-251	IC₅₀	0.26 μM Compound: 4-c	Antiproliferative activity against human Temozolomide-resistant U-251 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay Antiproliferative activity against human Temozolomide-resistant U-251 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay	[PMID: 37172473]
U-251	IC₅₀	1.09 μM Compound: 4-c	Antiproliferative activity against human Temozolomide-sensitive U-251 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay Antiproliferative activity against human Temozolomide-sensitive U-251 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay	[PMID: 37172473]
U-373MG ATCC	IC₅₀	0.89 μM Compound: 4-c	Antiproliferative activity against human U373 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method Antiproliferative activity against human U373 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method	[PMID: 37172473]
U-87MG ATCC	IC₅₀	0.36 μM Compound: 4-c	Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method	[PMID: 37172473]

In Vitro

MAO A/HSP90-IN-2 (compound 4-C) inhibits the growth of mouse and human GBM, colon cancer, leukemia, non-small cell lung and other cancers (GL26, U251S, U251R, U87MG, U373MG and LN229 cells with the IC₅₀ values of 0.49, 1.09 0.26, 0.36, 0.89 and 0.31 μM) ^[1].
MAO A/HSP90-IN-2 (0.3 - 3 μM, 24h) increases the expression of HSP70，and decreases HER2 and phospho-Akt expression in GL26 and U251R cell lines ^[1].
MAO A/HSP90-IN-2(0.5 - 1 μM, 24 h) inhibits IFN-γ induced PD-L1 expression concentration-dependently in GL26 cells ^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis ^[1]

Cell Line:

GL26, U251R cells
Concentration:

0.1, 0.3, 1, 3 μM
Incubation Time:

24 h
Result:

Decreased HER2 and phospho-Akt expression and increased the expression of HSP70 in a dose-dependent manner.

In Vivo

MAO A/HSP90-IN-2(compound 4-C) (25 mg/kg for i.p., eight days) reduces tumor growth in GL26 orthotopic xenograft tumor models^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

GL26 orthotopic xenograft tumor models^[1]
Dosage:

25mg/kg
Administration:

Intraperitoneal injection (i.p.)
Result:

Reduced tumor growth inhibition (TGI%) by 59.8% compared to the control group.

Chemical Information

CAS No. 2927489-99-2
Molecular Weight 458.98
Formula C₂₅H₃₁ClN₂O₄
SMILES

O=C(C1=C(C=C(C(C(C)C)=C1)O)O)N(C2=CC(Cl)=C(C=C2)OCCCN(CC#C)C)CC
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (270 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. 1、Hui-Ju Tseng, et al. Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma. European Journal of Medicinal Chemistry. Volume 256, 5 August 2023, 115459.

[2]. Hui-Ju Tseng, et al. Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma. European Journal of Medicinal Chemistry. Volume 256, 5 August 2023, 115459. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote

Amount: USD 0.00

Biological Activity
- Description
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Purity & Documentation
References

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

MAO A/HSP90-IN-2

All Monoamine Oxidase Isoforms

All HSP Isoforms

Biological Activity

Chemical Information

Purity & Documentation

References

Calculators

Help & FAQs

MAO A/HSP90-IN-2 Related Classifications

HY-155580 Related Classifications